Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

8-K - Current report

Form Type: 8-K

Filing Date: 2021-06-14

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2021-06-14

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2021-06-07

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2021-06-04

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2021-06-04

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2021-06-04

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2021-05-24

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2021-05-19

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2021-05-13

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2021-05-07

View Filing